Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96


Markedly Increased High-Mobility Group Box 1 Protein in a Patient with Small-for-Size Syndrome.

Craig DG, Lee P, Pryde EA, Hidalgo E, Hayes PC, Wigmore SJ, Forbes SJ, Simpson KJ.

Case Rep Transplant. 2014;2014:272498. doi: 10.1155/2014/272498. Epub 2014 Jan 29.


Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.

Basta G, Del Turco S, Navarra T, Lee WM; Acute Liver Failure Study Group.

Liver Transpl. 2015 Jun;21(6):847-54. doi: 10.1002/lt.24129.


Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction.

Wang J, Wang H, Shi J, Ding Y.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12028-40. eCollection 2015.


Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE.

Romero R, Chaiworapongsa T, Savasan ZA, Hussein Y, Dong Z, Kusanovic JP, Kim CJ, Hassan SS.

J Matern Fetal Neonatal Med. 2012 Jun;25(6):558-67. doi: 10.3109/14767058.2011.599083.


Reduced soluble RAGE is associated with disease severity of axonal Guillain-Barré syndrome.

Zhang DQ, Wang R, Li T, Zhou JP, Chang GQ, Zhao N, Yang LN, Zhai H, Yang L.

Sci Rep. 2016 Feb 23;6:21890. doi: 10.1038/srep21890.


The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.

Bobek D, Grčević D, Kovačić N, Lukić IK, Jelušić M.

Pediatr Rheumatol Online J. 2014 Dec 3;12:50. doi: 10.1186/1546-0096-12-50. eCollection 2014.


Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome.

Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Maeda S, Yamagishi S.

Clin Biochem. 2011 Jun;44(8-9):601-4. doi: 10.1016/j.clinbiochem.2010.12.014. Epub 2011 Jan 3.


Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.

Jabaudon M, Blondonnet R, Roszyk L, Pereira B, Guérin R, Perbet S, Cayot S, Bouvier D, Blanchon L, Sapin V, Constantin JM.

PLoS One. 2015 Aug 14;10(8):e0135857. doi: 10.1371/journal.pone.0135857. eCollection 2015.


High-mobility group box-1 and receptor for advanced glycation end products in preterm infants with brain injury.

Lu HY, Ma JL, Shan JY, Zhang J, Wang QX, Zhang Q.

World J Pediatr. 2017 Jun;13(3):228-235. doi: 10.1007/s12519-016-0077-z. Epub 2016 Dec 20.


Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.

Smit PJ, Guo WA, Davidson BA, Mullan BA, Helinski JD, Knight PR 3rd.

J Surg Res. 2014 Sep;191(1):214-23. doi: 10.1016/j.jss.2014.04.001. Epub 2014 Apr 8.


Plasma concentrations of high-mobility group box protein 1, soluble receptor for advanced glycation end-products and circulating DNA in patients with acute pancreatitis.

Kocsis AK, Szabolcs A, Hofner P, Takács T, Farkas G, Boda K, Mándi Y.

Pancreatology. 2009;9(4):383-91. doi: 10.1159/000181172. Epub 2009 May 19.


High levels of circulating HMGB1 as a biomarker of acute liver failure in patients with viral hepatitis E.

Majumdar M, Ratho R, Chawla Y, Singh MP.

Liver Int. 2013 Oct;33(9):1341-8. doi: 10.1111/liv.12197. Epub 2013 May 19.


Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.

Heilmann RM, Otoni CC, Jergens AE, Grützner N, Suchodolski JS, Steiner JM.

Vet Immunol Immunopathol. 2014 Oct 15;161(3-4):184-92. doi: 10.1016/j.vetimm.2014.08.003. Epub 2014 Aug 13.


Serum levels of HMGB1 and sRAGE are associated to extraglandular involvement and disease activity as defined by ESSDAI in Sjögren's syndrome.

Kanne AM, Jülich M, Mahmutovic A, Tröster I, Sehnert B, Urbonaviciute V, Voll RE, Kollert F.

Arthritis Care Res (Hoboken). 2017 Sep 21. doi: 10.1002/acr.23420. [Epub ahead of print]


Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.

Yu SL, Wong CK, Szeto CC, Li EK, Cai Z, Tam LS.

Lupus. 2015 Jun;24(7):675-86. doi: 10.1177/0961203314559631. Epub 2014 Nov 18.


Involvement of the receptor for advanced glycation end products in liver transplantation.

Navarra T, De Simone P, Del Turco S, Filipponi F, Basta G.

Ann Hepatol. 2015 Mar-Apr;14(2):190-7.


The receptor for advanced glycation end products in ventilator-induced lung injury.

Kuipers MT, Aslami H, Tuinman PR, Tuip-de Boer AM, Jongsma G, van der Sluijs KF, Choi G, Wolthuis EK, Roelofs JJ, Bresser P, Schultz MJ, van der Poll T, Wieland CW.

Intensive Care Med Exp. 2014 Dec;2(1):22. doi: 10.1186/s40635-014-0022-1. Epub 2014 Aug 2.


Circulating levels of a soluble form of receptor for advanced glycation end products and high-mobility group box chromosomal protein 1 in patients with acute pancreatitis.

Lindström O, Tukiainen E, Kylänpää L, Mentula P, Rouhiainen A, Puolakkainen P, Rauvala H, Repo H.

Pancreas. 2009 Nov;38(8):e215-20. doi: 10.1097/MPA.0b013e3181bb59a7.


The role of intracellular high-mobility group box 1 in the early activation of Kupffer cells and the development of Con A-induced acute liver failure.

Yang Q, Liu Y, Shi Y, Zheng M, He J, Chen Z.

Immunobiology. 2013 Oct;218(10):1284-92. doi: 10.1016/j.imbio.2013.04.011. Epub 2013 Apr 27.


Supplemental Content

Support Center